Data / Drug companies / Diphenhydramine hydrochloride, naproxen sodium
Diphenhydramine hydrochloride, naproxen sodium: 12 companies and 12 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Diphenhydramine hydrochloride, naproxen sodium is listed in the FDA National Drug Code Directory by 12 companies, with 12 products in commercial distribution. 12 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on April 27, 2026.
The request: Get every company that lists diphenhydramine hydrochloride, naproxen sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 12
- Generic (ANDA) products
- 12 (100.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Naproxen Sodium PM, Good Sense Naproxen Sodium, Topcare All Night Pain Relief PM, Up and Up Naproxen Sodium PM, All Night Pain Relief PM, Naproxen Sodium PM, Equaline Naproxen Sodium PM, Basic Care Naproxen Sodium PM
- openFDA record search
- api.fda.gov
Companies that list diphenhydramine hydrochloride, naproxen sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amazon.com Services LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 10, 2021 |
| American Sales Company | 1 | tablet, film coated | Generic drugs (ANDA) | February 25, 2020 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet, film coated | Generic drugs (ANDA) | July 10, 2020 |
| H E B | 1 | tablet, film coated | Generic drugs (ANDA) | October 13, 2020 |
| Kroger Company | 1 | tablet | Generic drugs (ANDA) | June 20, 2019 |
| L. Perrigo Company | 1 | tablet, film coated | Generic drugs (ANDA) | December 28, 2018 |
| Meijer Distribution Inc | 1 | tablet, film coated | Generic drugs (ANDA) | January 14, 2020 |
| Safeway | 1 | tablet, film coated | Generic drugs (ANDA) | March 13, 2025 |
| Target Corporation | 1 | tablet, film coated | Generic drugs (ANDA) | January 25, 2022 |
| Topco Associates LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 8, 2019 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet, film coated | Generic drugs (ANDA) | December 17, 2019 |
| Walgreen Company | 1 | tablet, film coated | Generic drugs (ANDA) | April 27, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 11 | 91.7% |
| Tablet | 1 | 8.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 12 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 12 |
| Nonsteroidal Anti-inflammatory Drug | 12 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.